Beclometasone



Indications and Reactions:

Role Indications Reactions
Primary
Asthma 50.0%
Prophylaxis 19.2%
Bronchitis 7.7%
Drug Use For Unknown Indication 7.7%
Bronchitis Chronic 3.8%
Emphysema 3.8%
Oral Candidiasis 3.8%
Product Used For Unknown Indication 3.8%
Cerebrovascular Accident 16.7%
Psychotic Disorder 16.7%
Tooth Disorder 16.7%
Anosmia 8.3%
Drug Exposure During Pregnancy 8.3%
Lymphadenopathy 8.3%
Psoriasis 8.3%
Systemic Candida 8.3%
Tremor 8.3%
Secondary
Asthma 37.5%
Product Used For Unknown Indication 22.5%
Chronic Obstructive Pulmonary Disease 15.0%
Prophylaxis 7.5%
Diabetes Mellitus 5.0%
Hypertension 5.0%
Cerebrovascular Accident 2.5%
Coronary Artery Disease 2.5%
Migraine 2.5%
Bronchopulmonary Aspergillosis Allergic 30.0%
Cerebrovascular Accident 30.0%
Neurological Decompensation 10.0%
Paternal Drugs Affecting Foetus 10.0%
Vascular Dementia 10.0%
Weight Decreased 10.0%
Concomitant
Product Used For Unknown Indication 54.4%
Drug Use For Unknown Indication 9.6%
Asthma 7.6%
Chronic Obstructive Pulmonary Disease 3.7%
Prophylaxis 2.9%
Hypertension 2.8%
Depression 1.9%
Rheumatoid Arthritis 1.8%
Atrial Fibrillation 1.6%
Pain 1.6%
Prostate Cancer 1.5%
Hiv Infection 1.4%
Non-small Cell Lung Cancer Metastatic 1.4%
Acute Graft Versus Host Disease 1.3%
Schizophrenia 1.3%
Cough 1.2%
Infection Prophylaxis 1.1%
Type 2 Diabetes Mellitus 1.1%
Constipation 0.9%
Oedema Peripheral 0.9%
Wheezing 10.4%
Pneumonia 6.6%
Teeth Brittle 6.6%
Contusion 5.7%
Miosis 5.7%
Psychomotor Hyperactivity 5.7%
Transient Ischaemic Attack 5.7%
Vomiting 5.7%
White Blood Cell Count Increased 5.7%
Lower Respiratory Tract Infection 4.7%
Poor Quality Sleep 4.7%
Vision Blurred 4.7%
Withdrawal Syndrome 4.7%
Decreased Appetite 3.8%
Rash Generalised 3.8%
Renal Impairment 3.8%
Sepsis 3.8%
Anaphylactic Reaction 2.8%
Dyspnoea 2.8%
General Physical Health Deterioration 2.8%